Moody Lynn & Lieberson LLC boosted its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 111.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,639 shares of the company’s stock after buying an additional 3,505 shares during the period. Moody Lynn & Lieberson LLC’s holdings in Henry Schein were worth $1,174,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of HSIC. Quadrant Capital Group LLC raised its position in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares during the last quarter. Montag & Caldwell LLC raised its position in Henry Schein by 0.3% in the second quarter. Montag & Caldwell LLC now owns 2,700 shares of the company’s stock worth $477,000 after buying an additional 7 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its position in Henry Schein by 0.9% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 6,312 shares of the company’s stock worth $1,115,000 after buying an additional 54 shares during the last quarter. Retirement Systems of Alabama raised its position in Henry Schein by 0.3% in the second quarter. Retirement Systems of Alabama now owns 41,838 shares of the company’s stock worth $7,397,000 after buying an additional 105 shares during the last quarter. Finally, Shell Asset Management Co. raised its position in Henry Schein by 0.3% in the second quarter. Shell Asset Management Co. now owns 53,488 shares of the company’s stock worth $9,457,000 after buying an additional 141 shares during the last quarter. Institutional investors and hedge funds own 92.03% of the company’s stock.
Shares of Henry Schein Inc. (NASDAQ:HSIC) traded up 0.31% during trading on Tuesday, reaching $153.69. 361,959 shares of the company traded hands. The stock has a market capitalization of $12.57 billion, a PE ratio of 26.04 and a beta of 1.05. Henry Schein Inc. has a 12 month low of $142.64 and a 12 month high of $183.00. The company has a 50-day moving average of $161.88 and a 200-day moving average of $169.89.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.63 by $0.01. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.46 earnings per share. Analysts forecast that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.
A number of brokerages have weighed in on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Monday. Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $176.00 to $164.00 in a report on Friday. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a report on Tuesday, October 11th. Finally, Bank of America Corp. began coverage on shares of Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $159.50.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction on Monday, August 29th. The shares were sold at an average price of $164.03, for a total value of $554,585.43. Following the transaction, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.27% of the stock is currently owned by company insiders.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.